Hosted on MSN

BD expands recall of its Alaris Pump Module model 8100

The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
Yahoo

FDA flags risk from dropped BD Alaris pumps after 2 injury reports

BD has written to users of its Alaris pump modules about a risk associated with two complaints of serious injury. The Food and Drug Administration, which shared details of the letter Friday, has ...
Yahoo Finance

BD expands Class I recall to cover 15 more Alaris pump infusion sets

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...
Yahoo Finance

BD to pay $175M to settle charges of misleading investors on Alaris pump

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD will pay a $175 million civil penalty to settle charges ...
Nasdaq

BD Provides Update on Voluntary Recalls of Alaris(TM) Pump Module Model 8100 and Certain Alaris(TM) Pump Infusion Sets

FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...
Monthly Prescribing Reference

Compatibility Issues Prompt Recall of Alaris Infusion Pumps

To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...